Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 13/20 | 0.56 |
| ▸ | GRIN3B | O60391 | 13/20 | 0.56 |
| ▸ | GRIN1 | Q05586 | 13/20 | 0.56 |
| ▸ | GRIN2A | Q12879 | 13/20 | 0.56 |
| ▸ | GRIN2B | Q13224 | 13/20 | 0.56 |
| ▸ | GRIN2C | Q14957 | 13/20 | 0.56 |
| ▸ | GRIN3A | Q8TCU5 | 13/20 | 0.56 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 3/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4704929 | 0.88 | GRIN2D (0.61) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL463673 | 0.78 | GRIN2D (0.52) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL4704585 | 0.78 | CASP7 (0.58) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL1238471 | 0.74 | DAO (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30355132 | 0.74 | DAO (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30355127 | 0.74 | DAO (0.60) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30807513 | 0.74 | GRIN2D (0.67) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30807512 | 0.74 | GRIN2D (0.67) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL18548573 | 0.73 | CYP19A1 (0.49) | LMNAHPGD | |
| SCHEMBL16627567 | 0.73 | METAP2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11603431-B2 | Organic semiconductors | Raynergy Tek Incorporation (TW) | 2023-03-14 | — | — | US | disclosed |
| EP-3411374-B9 | [1,5]NAPHTHYRIDINE COMPOUNDS AND POLYMERS AS SEMICONDUCTORS | RAYNERGY TEK INC (TW) | 2023-01-11 | — | — | EP | disclosed |
| EP-3411374-B9 | [1,5]NAPHTHYRIDINE COMPOUNDS AND POLYMERS AS SEMICONDUCTORS | RAYNERGY TEK INC (TW) | 2023-01-11 | — | — | EP | disclosed |
| EP-3411374-B1 | [1,5]NAPHTHYRIDINE COMPOUNDS AND POLYMERS AS SEMICONDUCTORS | RAYNERGY TEK INC (TW) | 2022-08-10 | — | — | EP | disclosed |
| US-20190040188-A1 | ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2019-02-07 | — | — | US | disclosed |
| US-20190040188-A1 | ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2019-02-07 | — | — | US | disclosed |
| EP-3411374-A1 | [1,5]NAPHTHYRIDINE COMPOUNDS AND POLYMERS AS SEMICONDUCTORS | Merck Patent GmbH (DE) | 2018-12-12 | — | — | EP | disclosed |
| WO-2017133752-A1 | [1,5]NAPHTHYRIDINE COMPOUNDS AND POLYMERS AS SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017133752-A1 | [1,5]NAPHTHYRIDINE COMPOUNDS AND POLYMERS AS SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2017-08-10 | — | — | WO | disclosed |
| US-20150307465-A1 | Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use | MERCK SHARP & DOHME CORP. (US) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040188-A1 | ORGANIC SEMICONDUCTORS | OCIAD2, OCIAD1, PPOX | GRIN2D 136/4885GRIN3B 2224/4885GRIN1 1688/4885 |
| US-11603431-B2 | Organic semiconductors | OCIAD2, OCIAD1, PPOX | GRIN2D 136/4885GRIN3B 2224/4885GRIN1 1688/4885 |
| US-20150307465-A1 | Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use | BACE1, BACE2, APP | GRIN2D 2349/4885GRIN3B 3669/4885GRIN1 2510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.